Disc Medicine Opco (NASDAQ:IRON – Get Rating) had its price target boosted by equities researchers at Stifel Nicolaus from $50.00 to $65.00 in a note issued to investors on Friday, The Fly reports. Stifel Nicolaus’ price target suggests a potential upside of 23.88% from the stock’s current price. Several other research analysts have also commented […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) and Pliant Therapeutics (NASDAQ:PLRX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Analyst Recommendations This is a summary of recent […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) had its price target boosted by BMO Capital Markets from $40.00 to $70.00 in a research report sent to investors on Monday, The Fly reports. Other research analysts have also issued research reports about the stock. Cantor Fitzgerald increased their target price on shares of Disc Medicine Opco […]
Disc Medicine Opco (NASDAQ:IRON – Get Rating) had its price objective lifted by research analysts at Stifel Nicolaus from $40.00 to $50.00 in a research note issued to investors on Friday, The Fly reports. Stifel Nicolaus’ price target points to a potential upside of 7.53% from the company’s current price. A number of other brokerages […]